Europe sets sights on dud antibody tests amid COVID-19 free-for-all
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- S&P 500, Nasdaq eye tepid open as Middle East tensions weigh
- Fed’s Waller open to September rate hold—if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Abbott (ABT) Reports FreeStyle Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes
June 15, 2020 7:06 AM EDTAbbott (NYSE: ABT) announced today the U.S. Food and Drug Administration (FDA) cleared its next-generation FreeStyle® Libre 2 integrated continuous glucose monitoring (iCGM) system for adults and children ages 4 and older with diabetes. This is the only iCGM system with optional real-time alarms that measures glucose levels every minute, meeting the highest level of accuracy standards5 over 14 days, including superior day one1 accuracy compared to the other iCGM and excellent accuracy and alarm performance at low end glucose levels.6 With a 14-day wear time, the FreeStyle Libre 2 system is the longest-lasting,... More
Abbott (ABT) Declares $0.36 Quarterly Dividend; 1.6% Yield
June 12, 2020 10:29 AM EDTAbbott (NYSE: ABT) declared a quarterly dividend of $0.36 per share, or $1.44 annualized.
The dividend will be payable on August 17, 2020, to stockholders of record on July 15, 2020, with an ex-dividend date of July 14, 2020.
The annual yield on the dividend is 1.6 percent.
For a... More
